ReviewFrontiers in pharmacology2022
Recent advances on development of p21-activated kinase 4 inhibitors as anti-tumor agents.
Yang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewFrontiers in pharmacology2022
Yang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.